Shortages of estrogen patches have spread to injectable and vaginal hormone treatments as demand for menopause therapy rises, ...

Demand for menopause drugs is now outpacing supply across multiple estrogen products in the US. After months of tight supplies of estrogen patches, pharmacies and drug-shortage trackers say some ...

Women in the US struggling to find hormone replacement ⁠treatments ⁠to manage menopause symptoms are facing shortages beyond ...

Interest in the hormone treatment — which can involve a combination of estrogen and progestin via pill, transdermal patch, ...

A hot new hormone therapy (HT) option just hit the villa. This week, the FDA announced the approval of a generic form of ...

Tammy Duckworth, Kirsten Gillibrand and Adam Schiff urge the FDA to address the estradiol patch shortage disrupting menopause ...

October 26, 2026 U.S. Senator Kirsten Gillibrand (D-NY) pressed the Food and Drug Administration (FDA) on its plan to mitigate the estradiol transdermal patch shortage, which is making it ...

Low-dose transdermal estradiol may be an effective option for refractory vasomotor symptoms in transgender men without ...

FDA approved the first generic Climara Pro, a weekly estrogen-progestin patch, as women report trouble filling patches. What ...

Estrogen patches are the most commonly reported shortage in the U.S., but the FDA says it’s working to boost supply.

Women looking for relief from menopause symptoms could soon have a more affordable option for a weekly hormone patch.